November 18, 2026
Health news, explained with evidence
LIVE

Immune Cell Protein Identified as Potential Driver of Age-Related Organ Damage

🧠 AI Analysis 2 min read 👁 4

Monash University researchers found that blocking the protein granzyme K in mice reduced age-related damage to the heart, liver, and kidneys without affecting normal immune aging.

Immune Cell Protein Identified as Potential Driver of Age-Related Organ Damage🧠AI Analysis

Photo: Medical Xpress

Key points

  • Granzyme K levels increase with age and contribute to structural damage in the heart, liver, and kidneys.
  • Mice lacking the protein maintained better organ function and reduced tissue scarring even as their immune systems aged normally.
  • Analysis of human data showed elevated granzyme K in patients with conditions like heart failure and lupus nephritis.

Researchers at Monash University have identified a protein produced by immune cells, known as granzyme K, that appears to play a central role in age-related damage to vital organs. In a study published in the journal Immunity, senior researcher Professor Nicole La Gruta and her team found that eliminating this protein in mice protected their heart, liver, and kidneys from common markers of aging and tissue scarring.

The experimental mice lacking granzyme K demonstrated improved cardiac function and reduced fibrosis—scar tissue that hinders normal organ performance—compared to standard older mice. Interestingly, these protective effects occurred while the animals' immune systems continued to age as expected. The result suggests that organ decline and immune degradation may not be inextricably linked, offering a distinct pathway for targeted interventions.

Complementary analysis of human biological data revealed elevated levels of granzyme K in individuals suffering from inflammatory and fibrotic conditions, including lupus nephritis and heart failure. However, experts note key limitations: the research relied on genetically modified mice missing the protein from birth. Scientists are currently evaluating whether blocking granzyme K later in life yields identical benefits, and whether the findings will apply to human biology.

What to know: This early-stage discovery highlights a possible key driver of chronic organ damage, but approved treatments targeting granzyme K do not yet exist. Individuals seeking to maintain organ health as they age should discuss established lifestyle and medical management plans with their primary care physician.

Source Medical Xpress — medicalxpress.com/news/2026-11-scientists-protein-age.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.